Severe Jaundice in a COVID-19 Patient–Virus or Drug?
- 1 May 2021
- journal article
- letter
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 11 (3) , 407-408
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- COVID-19 and the liverJournal of Hepatology, 2020
- Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation: a propensity-weighted nationwide cohort studyScientific Reports, 2020
- Pathogenesis of Liver Injury in Coronavirus Disease 2019Journal of Clinical and Experimental Hepatology, 2020
- Cholestatic liver injury as a side-effect of dabigatran and the use of coagulation tests in dabigatran intoxication and after reversal by idarucizumab in bleeding and sepsisScandinavian Journal of Clinical and Laboratory Investigation, 2017
- Drug HepatotoxicityClinics in Liver Disease, 2017